These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 16317580)

  • 1. Integrin alpha-2 and beta-3 gene polymorphisms and breast cancer risk.
    Langsenlehner U; Renner W; Yazdani-Biuki B; Eder T; Wascher TC; Paulweber B; Clar H; Hofmann G; Samonigg H; Krippl P
    Breast Cancer Res Treat; 2006 May; 97(1):67-72. PubMed ID: 16317580
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrin alpha-2 and beta-3 gene polymorphisms and colorectal cancer risk.
    Gerger A; Hofmann G; Langsenlehner U; Renner W; Weitzer W; Wehrschütz M; Wascher T; Samonigg H; Krippl P
    Int J Colorectal Dis; 2009 Feb; 24(2):159-63. PubMed ID: 18836731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of thrombophilic gene polymorphisms in branch retinal vein occlusion.
    Weger M; Renner W; Steinbrugger I; Cichocki L; Temmel W; Stanger O; El-Shabrawi Y; Lechner H; Schmut O; Haas A
    Ophthalmology; 2005 Nov; 112(11):1910-5. PubMed ID: 16157382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Association of the integrin gene polymorphisms with ischemic stroke and plasma lipid levels].
    Wei YS; Lan Y; Liu YG; Meng LQ; Xu QQ; Xie HY
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Apr; 26(2):211-5. PubMed ID: 19350519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel single nucleotide polymorphism of the cyclooxygenase-2 gene associated with breast cancer.
    Li F; Ren GS; Li HY; Wang XY; Chen L; Li J
    Clin Oncol (R Coll Radiol); 2009 May; 21(4):302-5. PubMed ID: 19138835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MDR1 C3435T polymorphism in patients with breast cancer.
    Turgut S; Yaren A; Kursunluoglu R; Turgut G
    Arch Med Res; 2007 Jul; 38(5):539-44. PubMed ID: 17560460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-based case-control study of VEGF gene polymorphisms and breast cancer risk among Chinese women.
    Kataoka N; Cai Q; Wen W; Shu XO; Jin F; Gao YT; Zheng W
    Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1148-52. PubMed ID: 16775174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 825C>T polymorphism of the G-protein beta-3 subunit gene (GNB3) and breast cancer.
    Krippl P; Langsenlehner U; Renner W; Yazdani-Biuki B; Wolf G; Wascher TC; Paulweber B; Samonigg H
    Cancer Lett; 2004 Mar; 206(1):59-62. PubMed ID: 15019160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P27 V109G Polymorphism is associated with lymph node metastases but not with increased risk of breast cancer.
    Naidu R; Har YC; Taib NA
    J Exp Clin Cancer Res; 2007 Mar; 26(1):133-40. PubMed ID: 17550142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ERCC2 genotypes and a corresponding haplotype are linked with breast cancer risk in a German population.
    Justenhoven C; Hamann U; Pesch B; Harth V; Rabstein S; Baisch C; Vollmert C; Illig T; Ko YD; Brüning T; Brauch H
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2059-64. PubMed ID: 15598761
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The V89L polymorphism in the 5-alpha-reductase type 2 gene and risk of breast cancer.
    van Gils CH; Onland-Moret NC; Roest M; van Noord PA; Peeters PH
    Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1194-9. PubMed ID: 14652280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A polymorphism in the G protein beta3-subunit gene is associated with bone metastasis risk in breast cancer patients.
    Clar H; Langsenlehner U; Krippl P; Renner W; Leithner A; Gruber G; Hofmann G; Yazdani-Biuki B; Langsenlehner T; Windhager R
    Breast Cancer Res Treat; 2008 Oct; 111(3):449-52. PubMed ID: 17978878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cyclooxygenase-2 (PTGS2) 8473T>C polymorphism is associated with breast cancer risk.
    Langsenlehner U; Yazdani-Biuki B; Eder T; Renner W; Wascher TC; Paulweber B; Weitzer W; Samonigg H; Krippl P
    Clin Cancer Res; 2006 Feb; 12(4):1392-4. PubMed ID: 16489098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer.
    Shih CM; Lee YL; Chiou HL; Chen W; Chang GC; Chou MC; Lin LY
    Lung Cancer; 2006 Apr; 52(1):15-20. PubMed ID: 16476505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphisms of SULT1A1 and SULT1E1 and the risk and survival of breast cancer.
    Choi JY; Lee KM; Park SK; Noh DY; Ahn SH; Chung HW; Han W; Kim JS; Shin SG; Jang IJ; Yoo KY; Hirvonen A; Kang D
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1090-5. PubMed ID: 15894657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substantial reduction in risk of breast cancer associated with genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes.
    Zhou Y; Yu C; Miao X; Tan W; Liang G; Xiong P; Sun T; Lin D
    Carcinogenesis; 2004 Mar; 25(3):399-404. PubMed ID: 14604886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of breast cancer in Australian women.
    Spurdle AB; Hopper JL; Chen X; McCredie MR; Giles GG; Venter DJ; Southey MC; Chenevix-Trench G
    Cancer Epidemiol Biomarkers Prev; 2002 May; 11(5):439-43. PubMed ID: 12010857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-10 promoter polymorphism is associated with decreased breast cancer risk.
    Langsenlehner U; Krippl P; Renner W; Yazdani-Biuki B; Eder T; Köppel H; Wascher TC; Paulweber B; Samonigg H
    Breast Cancer Res Treat; 2005 Mar; 90(2):113-5. PubMed ID: 15803357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caspase 9 promoter polymorphisms and risk of primary lung cancer.
    Park JY; Park JM; Jang JS; Choi JE; Kim KM; Cha SI; Kim CH; Kang YM; Lee WK; Kam S; Park RW; Kim IS; Lee JT; Jung TH
    Hum Mol Genet; 2006 Jun; 15(12):1963-71. PubMed ID: 16687442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The 5A/6A polymorphism of the matrix metalloproteinase 3 gene promoter and breast cancer.
    Krippl P; Langsenlehner U; Renner W; Yazdani-Biuki B; Köppel H; Leithner A; Wascher TC; Paulweber B; Samonigg H
    Clin Cancer Res; 2004 May; 10(10):3518-20. PubMed ID: 15161710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.